UTAH MEDICAL PRODUCTS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 700 shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-03-27
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 700.00 shares, a 76.67% decline from fiscal 2024.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 3.00K shares, a 650.00% increase from fiscal 2023.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 400.00 shares, a 80.00% decline from fiscal 2022.
- UTAH MEDICAL PRODUCTS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 2.00K shares, a 33.33% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month as first filed |
|---|---|---|
| 2025-12-31 | 700.00 shares 10-K · filed 2026-03-27 | |
| 2024-12-31 | 3.00K shares 10-K · filed 2026-03-27 | |
| 2023-12-31 | 400.00 shares 10-K · filed 2026-03-27 | |
| 2022-12-31 | 2.00K shares 10-K · filed 2025-03-26 | |
| 2021-12-31 | 3.00K shares 10-K · filed 2024-03-26 | |
| 2020-12-31 | 1.00K shares 10-K/A · filed 2023-03-28 | |
| 2019-12-31 | 2.00K shares 10-K · filed 2022-03-25 | |
| 2018-12-31 | 0.00 shares 10-K · filed 2021-03-26 | |
| 2017-12-31 | 12.00K shares 10-K · filed 2020-03-16 | |
| 2016-12-31 | 3.00K shares 10-K · filed 2019-03-14 | |
| 2015-12-31 | 7.00K shares 10-K · filed 2018-03-06 | |
| 2014-12-31 | 4.00K shares 10-K · filed 2017-03-08 | |
| 2013-12-31 | 3.00K shares 10-K · filed 2016-03-10 | 3.26K shares 10-K · filed 2014-03-12 |
| 2012-12-31 | 19.00K shares 10-K · filed 2015-03-12 | 19.39K shares 10-K · filed 2013-03-07 |
| 2011-12-31 | 24.61K shares 10-K · filed 2014-03-12 | |
| 2010-12-31 | 5.24K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |